MedDataX Logo

Interest of 18F-FDG Positron Emission Tomography in the Management of Fevers and Inflammatory Syndromes

NCT ID: NCT04001491

Last Updated: 2019-06-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-08-01

Study Completion Date

2020-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients aged 75 and over represent a heterogeneous population with fragile subjects who have a higher risk of poor tolerance to many tests and especially who have a risk of major functional loss in the event of hospitalization. It is therefore necessary to adapt our prescriptions and not to impose on these patients an examination that is unnecessary. Or on the contrary, not to do without, out of ignorance, a minimally invasive examination that could be useful to these patients.

In this study, the investigators wish to evaluate the interest of the Pet-Scan in the therapeutic management of these elderly patients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammation

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Inflammation Inflammatory syndromes fever Tomography Positron emission at 18F-FDG Elderly patients Internal medicine Pet-Scan

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged 75 years and over,
* Patients cared for at the HUS, in hospital or in consultation, during the defined period (from 01/05/2013 to 31/12/2018)
* Having had an 18FDG-PET/TDM
* For fever or inflammatory syndrome check-ups, regardless of the duration of the evolution and the examinations already carried out
* Patient who has not expressed opposition to the reuse of their data for the purposes of this research.

Exclusion Criteria

* Patient who has expressed opposition to participating in the study
* Known explanation for fever or inflammatory syndrome
* Subjects under legal protection
* Subject under the protection of justice
* Subject under guardianship or curatorship

Translated with www.DeepL.com/Translator
Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emmanuel ANDRES, MD, PhD

Role: STUDY_DIRECTOR

University Hospital, Strasbourg, France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service de Médecine Interne, diabète et maladies métaboliques - Médicale B

Strasbourg, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Emmanuel ANDRES, MD, PhD

Role: CONTACT

Phone: 33 3 88 11 50 66

Email: [email protected]

Carole GREUEZ, MD

Role: CONTACT

Phone: 33 3 88 11 50 66

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Emmanuel ANDRES, MD, PhD

Role: primary

Carole GREUEZ, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

7473

Identifier Type: -

Identifier Source: org_study_id